Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn's disease

Alimentary Pharmacology and Therapeutics

Volumn 18, Issue 11-12, 2003, Pages 1107-1112

  Castiglione, F ^a   Rispo, A ^a   Di Girolamo, E ^a   Cozzolino, A ^a   Manguso, F ^a   Grassia, R ^a   Mazzacca, G ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; METRONIDAZOLE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL OVERGROWTH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DRUG EFFICACY; FEMALE; HUMAN; HYDROGEN BREATH TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; BREATH TESTS; CIPROFLOXACIN; COLONIC DISEASES; CROHN DISEASE; FEMALE; GLUCOSE; HUMANS; ILEAL DISEASES; LACTULOSE; MALE; METRONIDAZOLE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0347694843     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2003.01800.x     Document Type: Article

References (23)

1. Rhodes JM, Middleton T, Jewell DP. The lactulose breath test as a diagnostic test for small bowel bacterial overgrowth. Scand J Gastroenterol 1979; 14: 333-6.
2. Hamilton I, Worsley BW, Cobden I et al. Simultaneous culture of saliva and jejunal aspirate in the investigation of small bowel bacterial overgrowth. Gut 1982; 23: 847-53.
3. Valdovinos MA, Camilleri M, Thomforde G et al. Reduced accuracy of 14C-D-xylose breath test for detecting of bacterial overgrowth in gastrointestinal motility disorders. Scand J Gastroenterol 1993; 28: 963-8.
4. Castiglione F, Del Vecchio Blanco G, Rispo A et al. Orocoecal transit time and bacterial overgrowth in patients with Crohn's disease. J Clin Gastroenterol 2000; 31: 63-6.
5. Hirikawa M, Iida M, Kohorogi N et al. Hydrogen breath test assessement of orocoecal transit time: comparison with barium meal study. Am J Gastroenterol 1988; 83: 1158-66.
6. 2 breath test for small intestinal bacterial overgrowth. Gastroenterology 1990; 98: 253-4.
7. Corazza GR, Menozzi MG, Strocchi A et al. The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology 1990; 98: 302-9.
8. Mishkin D, Boston FM, Blank D et al. The glucose breath-test: a diagnostic test for small bowel strictures in Crohn's disease. Dig Dis Sci 2002; 47: 489-94.
9. Funayama Y, Sasaki I, Naito H et al. Monitoring and antibacterial treatment for postoperative bacterial overgrowth in Crohn's disease. Dis Col Rectum 1999; 42: 1072-7.
10. Attar A, Flourie B, Rambaud JC et al. Antibiotic efficacy in small bowel bacterial overgrowth-related chronic diarrhoea: a crossover, randomised trial. Gastroenterology 1999; 117: 794-7.
11. Di Stefano M, Malservisi S, Veneto G et al. Rifaximin versus chlortetracycline in the short term treatment of small bowel bacterial overgrowth. Aliment Pharmacol Ther 2000; 14: 551-6.
12. Prantera C, Berto E, Scribano ML et al. Use of antibiotics in the treatment of active Crohn's disease: experience with metronidazole and ciprofloxacin. Ital J Gastroenterol Hepatol 1998; 30: 602-6.
13. Greenbool SL, Steinhart AH, Greenberg GR. Combination ciprofloxacin and metronidazole for active Crohn's disease. Can J Gastroenterol 1998; 12: 53-6.
14. Prantera C, Zannoni F, Scribano ML et al. An antibiotic regimen for the treatment of active Crohn's disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin. Am J Gastroenterol 1996; 91: 328-32.
15. 2 excretion following lactulose ingestion. Dig Dis Sci 1993; 38: 300-4.
16. Kerlin P, Wong L. Breath hydrogen testing in bacterial overgrowth of the small intestine. Gastroenterology 1988; 95: 982-8.
17. Corazza GR, Strocchi A, Gasbarrini G. Fasting breath hydrogen in celiac disease. Gastroenterology 1987; 93: 53-6.
18. Perman JA, Modier S, Barr RG et al. Fasting breath hydrogen concentration: normal values and clinical application. Gastroenterology 1984; 87: 1358-63.
19. Freeman CD, Klutman NE, Lamp KC. Metronidazole. A therapeutic review and update. Drugs 1997; 54: 679-708.
20. Appelbaum PC. Quinolone activity against anaerobes. Drugs 1999; 58: 60-4.
21. Borzio M, Salerno F, Sbudelli M et al. Efficacy of oral ciprofloxacin as selective intestinal decontamination in cirrhosis. Ital J Gastroenterol Hepatol 1997; 29: 262-6.
22. Tillonen J, Homann N, Rautio M et al. Ciprofloxacin decreases the rate of ethanol elimination in humans. Gut 1999; 44: 347-52.
23. Meddings JB. Review article: Intestinal permeability in Crohn's disease. Aliment Pharmacol Ther 1997; 11: 47-53.